Biogen Idec recently launched Tysabri for people living with multiple sclerosis (MS), the drug TYSABRI offers new hope in the management of this debilitating disease.

Biogen Idec engaged Seeclear Systems to develop an Access based Tysabri Australian Patient Prescribing application (TAPP). The stated objectives for this work were to build functionality to document who had been trained to prescribe Tysabri. We also provided means to communicate with those who had not completed compulsory training and provide reports to the TGA every 6 months on Tysabri’s use.

Seeclear Systems implemented the following services:

• Web Consulting
• Database Solutions